Searchable abstracts of presentations at key conferences in endocrinology

ea0011p36 | Bone | ECE2006

Assessment of bone mineral density (BMD) in patients with adrenal incidentaloma (ai): comparison between dual-energy x-ray absorptiometry (DEXA) and quantitative ultrasonometry (QUS)

Reimondo G , Bovio S , Ventura M , Osella G , Angeli A , Terzolo M

The aim of the present study was to compare the assessment of BMD measured either by DEXA or by QUS in patients with AI. We evaluated 40 patients with AI, who underwent an evaluation of hypothalamic-pituitary-adrenal (HPA) axis function and bone densitometry measured either by DEXA (Hologic QDR 4500 W) at lumbar spine and at femur or QUS (Achilles Express) at the right foot. Subclinical Cushing’s syndrome (SCS) was defined as abnormal response to at least 2 standard tests...

ea0011p523 | Endocrine tumours and neoplasia | ECE2006

Glucocorticoid receptor gene N363S variant in patients with clinically inapparent adrenal adenomas

Reimondo G , Micossi I , Giachino D , Bovio S , Allasino B , Daffara F , Angeli A , Terzolo M , De Marchi M

N363S polymorphism of the human glucocorticoid receptor gene has been detected in the heterozygous state in approximately 3–9% of general European population. This variant has been associated with increased sensitivity to glicocorticoids, increased insulin response to dexamethasone, a tendency towards lower bone mineral density, increased body mass index, and unstable angina. However, other reports found no associations with these pathological conditions. We assessed the ...